ABSTRACT: Edwardsiella tarda glyceraldehyde-3-phosphate dehydrogenase (GAPDH) may be an effective vaccine candidate against infection by E. tarda in Japanese flounder Paralichthys olivaceus. The GAPDH of E. tarda is highly homologous to that of Vibrio cholerae (91%), and therefore E. tarda GAPDH may have protective antigenicity against Vibrio species. In this study, we immunized Japanese flounder with GAPDH of E. tarda and infected the fish with V. anguillarum. The result showed that GAPDH prepared from E. tarda protected Japanese flounder effectively in a challenge of V. anguillarum. Therefore, E. tarda GAPDH should be considered as a multi-purpose vaccine candidate against several kinds of pathogenic bacteria.
INTRODUCTION
A 37 kDa outer membrane protein (OMP) among different serotype strains of Edwardsiella tarda is effective against infections by different serotype strains of E. tarda (Kawai et al. 2004) . N-terminal amino acid sequence analysis showed that the 37 kDa OMP is homologous to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a cytoplasmic enzyme common in organisms (Kawai et al. 2004) . To develop E. tarda GAPDH as a vaccine against E. tarda, Liu et al. (2005) obtained a sequence of the gene encoding E. tarda GAPDH, overexpressed the GAPDH protein, and evaluated the vaccine efficacy of expressed GAPDH against E. tarda infection. The GAPDH of both nucleotide and amino acid sequences are highly similar between E. tarda and other Gram-negative bacteria, and have especially high homologies between E. tarda and Vibrio cholerae (Liu et al. 2005) .
Vibrio sp. are the etiological agents of severe diarrheal diseases in fish and humans and cause epidemic diarrheal diseases that are feared because of their severity (Kusuda & Salati 1993 , Kaper et al. 1995 . The high similarities of GAPDH between Edwardsiella tarda and V. cholerae prompted us to examine the protective antigenicity of E. tarda GAPDH against Vibrio infection.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The Edwardsiella tarda EF-1 strain was cultured as described in Kawai et al. (2004) . Vibrio anguillarum strain 1122 (J-O-3) isolated from ayu Plecoglossus altivelis was pre-cultured in brain heart infusion (BHI, Difco) broth containing 2% NaCl at 25°C for 1 d, inoculated into new BHI broth containing 2% NaCl, and then cultured at 25°C for 18 h.
Antigen. The 37 kDa OMP of Edwardsiella tarda EF-1 strain was extracted as described (Suzuki et al. 1994) . The antigen underwent sodium dodecyl sul-phate polyacrylamide gel electrophoresis (SDS-PAGE) and was visualized by Coomassie brilliant blue staining. The prepared protein also underwent Western blotting by using antiserum against the E. tarda 37 kDa OMP (Kawai et al. 2004 ) and antiserum against general (human, rabbit, and Escherichia coli) GAPDH (Biogenesis), respectively.
Fish and immunization. Japanese flounder Paralichthys olivaceus weighing about 21 g were obtained from a hatchery in Kochi Prefecture, Japan, and were divided into 2 groups: Group 1 (n = 50) was immunized with the 37 kDa GAPDH prepared from Edwardsiella tarda (30 µg fish -1 ) by intraperitoneal injection, and Group 2 (n = 50) was intraperitoneally injected with phosphate-buffered saline (PBS; 100 µl fish -1 ) as a control. The fish were reared in aquaria for 4 wk and were infected with Vibrio anguillarum strain 1122.
Challenge test. The appropriate dose of Vibrio anguillarum for a challenge test was determined in a preliminary infection experiment. A broth culture of V. anguillarum strain 1122 was diluted to 5 different concentrations. Thirty Japanese flounder were intraperitoneally injected with each of the 5 diluted bacterial suspensions (Table 1 ). The number of injected V. anguillarum was counted on agar plates after serial dilutions.
Based on the results of this preliminary experiment, the immunized fish in the 2 groups were challenged by a dose of 4.0 × 10 6 colony-forming units (CFU) fish -1 with intraperitoneal injection. Mortality was recorded twice a day for 2 wk. Significant differences between the 2 groups were calculated by Fisher's exact test.
RESULTS
Fig . 1A shows a single band at the 37 kDa site (Lane 1), suggesting that the 37 kDa OMP was successfully separated from other OMPs. Fig. 1B shows that the protein reacted to the antiserum against 37 kDa OMP of Edwardsiella tarda (Lane 2) and antiserum against GAPDH (Lane 3). The results indicated that the prepared protein was the E. tarda 37 kDa GAPDH. Fig. 2 shows the survival rate of the Japanese flounder after infection with Vibrio anguillarum strain 1122. From the second day after infection, fish in the control group started to die, and the survival rate decreased sharply until the fifth day after infection to a final survival rate of 42%. The final survival rate of the immunized group was 90%. Fish immunized with 37 kDa OMP of Edwardsiella tarda maintained a markedly higher survival rate than the unimmunized fish; the 2 groups were significantly different (p < 0.005). This result suggested that E. tarda GAPDH has protective antigenicity against infection of V. anguillarum. 
DISCUSSION
GAPDH is historically recognized as a cytoplasmic enzyme in the glycolytic pathway (Dandliker & Fox 1955 , Fox & Dandliker 1956 ). Recent reports, however, have revealed that GAPDH binds to the cell membrane (Tsai et al. 1982 , Allen et al. 1987 , Modun & Williams 1999 and exists on the cell surface (Pancholi & Fischetti 1992 , Hughes et al. 2002 . As the surface GAPDH of Streptococcus agalactiae has no N-terminal signal peptide (Hughes et al. 2002) , the attaching mechanism of this protein to the cell membrane is unclear. Membrane-bound GAPDH has many functions, but the signal peptide does not have the classical function of catalyzing (Tsai et al. 1982 , Allen et al. 1987 , Pancholi & Fischetti 1992 , Modun & Williams 1999 , Argiro et al. 2000a ). Surface-located GAPDH of Gram-positive bacteria was reported to be a highly active receptor for host proteins and effective vaccine components (Seifert et al. 2003 , Bolton et al. 2004 . A 37 kDa surface GAPDH of Schistosoma mansoni is highly antigenic in the immune response of humans against schistosome infection (Argiro et al. 2000a) , and further research has demonstrated that GAPDH of S. mansoni carries B-cell epitope and associates with antibody induction (Argiro et al. 2000b ) in mice. Our previous study also showed that the 37 kDa OMP of E. tarda produced antibodies in fish and protected Japanese flounder against Edwardsiella tarda infection ( Kawai et al. 2004) .
GAPDH is widely present in Gram-positive bacteria (Iddar et al. 2005) and is a common protein of Gramnegative bacteria (Villamon et al. 2003) . Alignment of the GAPDH amino acid sequences of several Gramnegative bacteria (Escherichia coli, Salmonella enterica, Shigella flexneri , and Vibrio cholerae) showed that the sequences are highly conserved and the similarities between these bacteria are ≥80% (Liu et al. 2005) by using the DNA Data Bank of the Japan Homology Search System (www.ddbj.nig.ac.jp). The high conservation of the GAPDH among different pathogenic bacteria led to the idea that Edwardsiella tarda GAPDH might have protective antigenicity against other pathogenic bacteria. Thus, in the present study, Japanese flounder was immunized with the 37 kDa GAPDH of E. tarda and was challenged with V. anguillarum. An encouraging result showed that the immunized fish maintained a significantly higher survival rate than the unimmunized fish. The results were obtained with a non-adjuvanted antigen; thus, an even higher level of protection with an adjuvant might be expected. Results of the present study strongly suggest that the 37 kDa GAPDH of E. tarda may lead to the development of a multi-purpose vaccine against infection by different pathogenic bacteria.
GAPDH may be protective in several ways. The most reliable hypothesis is that immunization induces the production of antibodies in Japanese flounder (Kawai et al. 2004) , which inhibits the function of the pathogen GAPDH. A similar observation was made in studies on parasites, where the use of drugs that inhibit the enzymatic activity of GAPDH decreased the survival of the infecting parasite (Callens & Hannaert 1995 , Bourguignon et al. 1997 . Anti-GAPDH antibodies produced in the immunized flounder might have inhibited the GAPDH activity of the infecting Vibrio in the challenge test of the present study.
Generally, our study showed that the GAPDH of Edwardsiella tarda has protective antigenicity against infection by Vibrio anguillarum, and indicates that the GAPDH of E. tarda can be developed as a multipurpose vaccine against different pathogenic bacteria.
